Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients
A completed clinical trial evaluating whether serum ferritin can predict hepatic fibrosis in patients with non-alcoholic fatty liver disease…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)
This update reports the completed clinical trial NCT02884037 sponsored by Mansoura University, evaluating rifaximin for modifying the pathog…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluating a Mediterranean lifestyle intervention in patients with non-alcoholic fatty liver disease (NAFLD) and …
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference. [NA]
This completed multicenter prospective study assessed the diagnostic accuracy of CAP measurements by FibroScan (M+ or XL+ probes) for non-al…
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Nutritional Prevention of Diabetes Mellitus Type 2 [NA]
This completed clinical trial evaluates nutritional prevention strategies for Type 2 Diabetes Mellitus and assesses effects on liver fat and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver [NA]
This update notes that a clinical trial evaluating MRI-based quantification of liver fat has completed at University Hospital Basel, focusin…
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Response of NAFLD Patients to Mediterranean Diet [NA]
A completed clinical trial evaluated how patients with non-alcoholic fatty liver disease respond to a Mediterranean diet.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone [Phase 4]
Phase 4 study evaluating ipragliflozin on excess fat in people with type 2 diabetes and non-alcoholic fatty liver disease who are on metform…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease
A completed clinical trial from the University of Leipzig evaluating non-invasive liver screening as a risk assessment tool for coronary hea…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Sonoelastography: Ultrasound Method to Measure Liver Fibrosis [NA]
A completed clinical trial evaluated sonoelastography, an ultrasound method to measure liver fibrosis; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: The Effect of an RBAC Supplement (BRM4) on NAFLD [NA]
A completed clinical trial evaluated the effect of the RBAC supplement BRM4 on Non-Alcoholic Fatty Liver Disease.
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Histological Improvement of NASH With Prebiotic [NA]
A completed clinical trial investigated histological improvement in non-alcoholic fatty liver disease (NASH) using a prebiotic therapy, sugg…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease
Clinical trial update notes completion of a study examining autonomic dysfunction in non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Study of Losartan in the Treatment of NAFLD in Children [Phase 2]
Phase 2 study evaluating Losartan for treating non-alcoholic fatty liver disease in children has completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients [Phase 2]
Phase 2 trial evaluating amlexanox versus placebo in type 2 diabetes patients; results completed and posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents [Phase 2, Phase 3]
This clinical trial update describes Phase 2/Phase 3 testing of resveratrol for overweight adolescents with NAFLD and insulin resistance. Th…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth [NA]
A completed clinical trial validating HepaFat-Scan as a noninvasive method to measure hepatic steatosis in youth with non-alcoholic fatty li…
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluating whether a text messaging program can aid in the management of non-alcoholic fatty liver disease and no…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Antidiabetic Effects on Intrahepatic Fat [Phase 4]
A Phase 4 clinical trial investigating antidiabetic effects on intrahepatic fat in patients with non-alcoholic fatty liver disease and type …
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Ultrasound Method to Measure Fibrosis of the Liver in Children [NA]
Update on a pediatric ultrasound method to measure liver fibrosis; the trial was terminated and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients [Phase 2]
Phase 2 trial assessing the combined impact of Omega-3 carboxylic acids and dapagliflozin on liver fat content in patients with type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: The Sleep, Liver Evaluation and Effective Pressure Study [Phase 2]
Phase 2 clinical trial update from Johns Hopkins University evaluating sleep, liver function, and pressure in non-alcoholic fatty liver dise…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome [NA]
A completed clinical trial evaluated whether dairy fat affects vitamin E adequacy in people with metabolic syndrome, including non-alcoholic…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease [Phase 1]
Phase 1 clinical trial update: RO5093151 for non-alcoholic fatty liver disease (NAFLD) conducted by Hoffmann-La Roche has completed. The ent…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial comparing sitagliptin to placebo in non-alcoholic fatty liver disease has completed with results posted.